Monday, Dec 18, 2017
engineered enzymes for better healthcare

science-behind-research-and-development-150-small

Enzolve Technologies 是一家以研发为导向的创新型公司,它将其在酶方面的技术专长应用于各种专业领域。

  • Enzolve 开发和生产了专门用于医疗保健、精细化工和生命科学市场的酶。
  • 基于独家研制的工程酶,Enzolve 生产、开发和销售独特的平台技术以及基于酶的专业产品,用于临床诊断不对称合成。此研发的核心在于 NeoScreenPak,它是一套测试,可以筛检出 11 种婴儿最常见遗传性疾病中的 7 种。
  • Enzolve 为电泳后更佳的蛋白质可视化提供了新颖的解决方案。
  • Enzolve 还提供专家签约研究服务,以帮助公司或机构解决酶相关的问题。

免责声明

Language Selection

Search

Latest News

Newborn Screening - First Steps into the marketplace
Irish technology to enable metabolic disorder screening among newborns in the developing world and remote locations... Read full article on the web Technology…

Read more...

Screen your baby’s health
Enzolve Technologies recently launched a novel newborn screening test for Phenylketonuria (PKU), an inherited metabolic disorder that results in severe mental…

Read more...

UCD campus company to begin production of newborn screening kits for international markets
Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits…

Read more...